Polatuzumab Vedotin and Combination Chemotherapy for the Treatment of Previously Untreated Lymphoma

Clinical trial NCT04479267 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04479267
Sponsor: Barbara Ann Karmanos Cancer Institute
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Diffuse Large B-Cell Lymphoma High Grade B-Cell Lymphoma w/MYC & BCL2 or BCL6 Rearrangements High Grade B-Cell Lymphoma w/MYC, BCL2 & BCL6 Rearrangements Double Expressor Lymphoma High-grade B-cell Lymphoma

Start date: 2020-08-21
Primary completion: 2025-06-19
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.